Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hyperthermia × Ifosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 33 Sarcoma 32 Lymphoma, Large B-Cell, Diffuse 27 Lymphoma, Non-Hodgkin 18 Osteosarcoma 13 Hodgkin Disease 12 Burkitt Lymphoma 12 Testicular Neoplasms 9 Leukemia 9 Recurrence 8 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, Follicular 8 Lymphoma, B-Cell, Marginal Zone 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Teratoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Lymphoma, Mantle-Cell 6 Breast Neoplasms 6 Carcinoma, Embryonal 5 Urinary Bladder Neoplasms 4 Testicular Germ Cell Tumor 4 Neuroblastoma 4 Neoplasms, Germ Cell and Embryonal 4 Lymphoma, B-Cell 4 Endodermal Sinus Tumor 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3

Interventions

Diathermy 4 Radiotherapy 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Cisplatin 2 tislelizumab 1 sodium thiosulfate 1 anlotinib 1 Surgical Procedures, Operative 1 Radiation 1 Laparotomy 1 Ifosfamide 1 Fluorouracil 1 Drug Therapy 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡